Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART
- PMID: 26587072
- PMCID: PMC4645867
- DOI: 10.2174/1874613601509010051
Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART
Abstract
Background: The introduction and widespread use of combination antiretroviral therapy referred to as highly active antiretroviral therapy (HAART) in the mid 1990's, has led HIV-infected individuals to experience a dramatic decline in immunodeficiency-related events and death. There is growing concern on metabolic complications associated with HIV and HAART which may increase cardiovascular risk and disease. The aim of this study was to investigate the cardiovascular risk profile of HIV/AIDS patients receiving HAART and those not receiving HAART at HIV/AIDS treatment centres in the South West Region of Cameroon.
Methods: Consenting participants, who had been receiving HAART, were compared with HAART naive participants. A questionnaire was administered; anthropometric and blood pressure measurements were recorded under standard conditions. Blood samples were obtained for the determination of plasma glucose and lipid levels.
Results: Two hundred and fifteen participants were recruited, 160 (74.4%) were on HAART and 55 (25.6%) were HAART naive. Among the individual lipid abnormalities, increased total cholesterol was the most prevalent (40.0%). Participants on HAART were significantly about 8 times at risk of developing hypercholesterolemia when compared to the HAART inexperienced group (OR 8.17; 95% CI: 3.31-20.14; p<0.001). Hypertension had a prevalence of 25.6% (95% CI: 15.3%-35.9%) and was about 2 times significantly higher in the HAART treated than the HAART untreated group (p=0.033). The prevalence of low HDL-c was significantly higher in males (24.1%) compared to females (11.2%) (p=0.0196). Many females (27.3%) were obese compared to males (7.4%) (p=0.0043). HAART use and treatment duration of more than five years were significantly associated with higher prevalence of CVD risk factors.
Conclusion: HAART treatment was associated with significantly higher prevalence of hypercholesterolemia, increased LDL-c and hypertension, hence the risk of cardiovascular diseases.
Keywords: AIDS; Cameroon; Cardiovascular; HAART; HIV; dyslipidemia.
Similar articles
-
Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.BMC Cardiovasc Disord. 2015 Aug 28;15:95. doi: 10.1186/s12872-015-0090-5. BMC Cardiovasc Disord. 2015. PMID: 26315756 Free PMC article.
-
Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy.Niger Med J. 2013 May;54(3):185-90. doi: 10.4103/0300-1652.114591. Niger Med J. 2013. PMID: 23901181 Free PMC article.
-
Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.Ann Afr Med. 2013 Jan-Mar;12(1):24-8. doi: 10.4103/1596-3519.108246. Ann Afr Med. 2013. PMID: 23480991
-
Cardiovascular implications of HIV-induced dyslipidemia.Atherosclerosis. 2011 Dec;219(2):384-9. doi: 10.1016/j.atherosclerosis.2011.06.003. Epub 2011 Jun 13. Atherosclerosis. 2011. PMID: 21722900 Review.
-
Cardiology and AIDS--HAART and the consequences.Ann N Y Acad Sci. 2001 Nov;946:130-44. doi: 10.1111/j.1749-6632.2001.tb03908.x. Ann N Y Acad Sci. 2001. PMID: 11762982 Review.
Cited by
-
Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients.Biomedicines. 2021 Aug 9;9(8):987. doi: 10.3390/biomedicines9080987. Biomedicines. 2021. PMID: 34440191 Free PMC article.
-
Behavioral risk factors for hypertension among adults living with HIV accessing care in secondary health facilities in Lagos State, Nigeria.J Family Med Prim Care. 2020 Jul 30;9(7):3450-3457. doi: 10.4103/jfmpc.jfmpc_544_20. eCollection 2020 Jul. J Family Med Prim Care. 2020. PMID: 33102312 Free PMC article.
-
Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS.PLoS One. 2021 Jul 22;16(7):e0253742. doi: 10.1371/journal.pone.0253742. eCollection 2021. PLoS One. 2021. PMID: 34292956 Free PMC article. Clinical Trial.
-
The association between antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: A systematic review and meta-analysis.PLoS One. 2018 Jul 30;13(7):e0201404. doi: 10.1371/journal.pone.0201404. eCollection 2018. PLoS One. 2018. PMID: 30059546 Free PMC article.
-
Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making.South Afr J HIV Med. 2021 Jun 28;22(1):1246. doi: 10.4102/sajhivmed.v22i1.1246. eCollection 2021. South Afr J HIV Med. 2021. PMID: 34230861 Free PMC article.
References
-
- Report G. UNAIDS report on the global AIDS epidemic.
-
- Global update on HIV treatment 2013: results, impact and opportunities. http://www.who.int/hiv [Accessed: February 10, 2014.] 2013.
-
- Grinsztejn B., Luz P.M., Pacheco A.G., Santos D.V., Velasque L., Moreira R.I., Guimarães M.R., Nunes E.P., Lemos A.S., Ribeiro S.R., Campos D.P., Vitoria M.A., Veloso V.G. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One. 2013;8(4):e59768. doi: 10.1371/journal.pone.0059768. [INSERT FIGURE 001]. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources